medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2019, Number 3

<< Back Next >>

Rev Mex Oftalmol 2019; 93 (3)

Pediatric glaucomas: clinical features and treatment in a tertiary referral hospital in Mexico City

Güémez-Graniel MF, Navarro-Peña MC, Ramírez-Ortiz MA

Language: Spanish
References: 22
Page: 137-141
PDF size: 105.77 Kb.


ABSTRACT

Pediatric glaucomas are a heterogenous group of eye diseases associated in some cases to genetic syndromes. The objective of this study is to identify the different etiologies of glaucoma in children and to describe medical and surgical treatments in these patients in a tertiary referral hospital. Patients and Methods: Retrospective, descriptive and transversal study. Medical records analysis of patients diagnosed with glaucoma from 2011 to 2015. Age at diagnosis, laterality, etiology, associated syndromes, medical and surgical treatment and follow-up were gathered. Results: We identified 77 patients. Average age at diagnosis was 2.27 years. There was no gender predilection. The most frequent etiology was primary congenital glaucoma (63%) followed by glaucoma secondary to cataract surgery (19%). Sixty percent of all cases were bilateral. All patients un-derwent examination under anesthesia. Sixty-two patients (80%) required surgical treatment. There were 15 systemic and genetic diseases associated with pediatric glaucoma. Only two thirds of all patients continued their follow-up. Conclusions: Pediatric glaucomas are a challenge for ophthalmologists because they comprise a complex group of eye diseases with a difficult clinical approach due to systemic and genetic abnormalities, delayed diagnosis and high frequency of surgical treatment along with lack of follow-up.


REFERENCES

  1. Zepeda-Romero LC, Barrera-de-Leon JC, Camacho-Choza C, Gonzalez Bernal C, Camarena-Garcia E, Diaz-Alatorre C, Gutierrez-Padilla JA, Gilbert C. Retinopathy of prematurity as a major cause of severe visual impairment and blindness in children in schools for the blind in Guadalajara city, Mexico. Br J Ophthalmol. 2011;95:1502-5.

  2. Steinkuller PG, Du L, Gilbert C, Foster A, Collins ML, Coats DK. Childhood blindness. JAAPOS. 1999;3:26-32.

  3. Fung DS, Roensch MA, Kooner KS, Cavanagh HD, Whitson JT. Epidemiology and characteristics of childhood glaucoma: results from the Dallas Glaucoma Registry. Clin Ophthalmol. 2013;7:1739-46.

  4. Yeung HH, Walton DS. Clinical classification of childhood glaucomas. Arch Ophthalmol. 2010;128: 680-4.

  5. Cortés V, Villanueva C. Epidemiología del glaucoma congénito en la Asociación para Evitar la Ceguera en México, revisión de 5 años. Rev Mex Oftalmol. 2015;89:150-3.

  6. Moore DB, Tomkins O, Ben-Zion I. A review of primary congenital glaucoma in the developing world. Surv Ophthalmol. 2013;58:278-85.

  7. Papadopoulos M, Cable N, Rahi J, Tee Khaw P, BIG Eye Study Investigators. The British Infantile and Childhood Glaucoma (BIG) Eye Study. IOVS. 2007;48:4100-7.

  8. Taylor RH, Ainsworth JR, Evans AR, Levin AV. The epidemiology of pediatric glaucoma: the Toronto experience. JAAPOS. 1999;3:308-15.

  9. Fung DS, Roensch MA, Kooner KS, Cavanagh HD, Whitson JT. Epidemiology and characteristics of childhood glaucoma: results from the Dallas Glaucoma Registry. Clin Ophthalmol. 2013;7:1739-46.

  10. Freedman SF, Lynn MJ, Beck AD, Bothun ED, Örge FH, Lambert SR. Glaucoma-related adverse events in the first five years after unilateral cataract removal in the Infant Aphakia Treatment Study. JAMA Ophthalmol. 2015;133:907-14.

  11. Mantelli F, Bruscolini A, La Cava M, Abdolrahimzadeh S, Lambiase A. Ocular manifestations of Sturge–Weber syndrome: pathogenesis, diagnosis, and management. Clinical Ophthalmol. 2016;10: 871-8.

  12. Mullaney PB, Selleck C, Al-Awad A, Al-mesfer S, Zwaan J, Combined trabeculotomy and trabeculectomy as an initial procedure in uncomplicated congenital glaucoma. Arch Ophthalmol. 1999;117:457-60.

  13. Balekudaru S, Vadalkar J, George R, Vijaya L. The use of Ahmed glaucoma valve in the management of pediatric glaucoma. J AAPOS. 2014; 18:351-6.

  14. Morad Y, Donaldson CE, Kim YM, Abdolell M, Levin AV. The Ahmed drainage implant in the treatment of pediatric glaucoma. Am J Ophthalmol. 2003;135: 821-9.

  15. Al-Omairi AM, Al Ameri AH, Al-Shahwan S, et al. Outcomes of Ahmed Glaucoma Valve Revision in Pediatric Glaucoma. Am J Ophthalmol. 2017;183:141-6.

  16. Boger WP 3rd, Walton DS. Timolol in uncontrolled childhood glaucomas. Ophthalmology. 1981;88:253-8.

  17. Plager DA, Whitson JT, Netland PA, et al. Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial. J AAPOS. 2009; 13:384-90.

  18. Sabri K, Levin AV. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma. J AAPOS. 2006;10:464-8.

  19. Coppens G, Stalmans I, Zeyen T, Casteels I. The safety and efficacy of glaucoma medication in the pediatric population. J Pediatr Ophthalmol Strabismus. 2009;46: 2-8.

  20. Wiggs JL. Genetic etiologies of glaucoma. Arch Ophthalmol. 2007;125: 30-7.

  21. Abdolrahimzadeh S, Fameli V, Mollo R, Contestabile MT, Perdicchi A, Recupero SM. Rare Diseases Leading to Childhood Glaucoma: Epidemiology, Pathophysiogenesis, and Management. Biomed Res Int. 2015;2015:781294.

  22. Zagora SL, Funnell CL, Martin FJ, Smith JE, Hing S, Billson FA, et al. Primary congenital glaucoma outcomes: lessons from 23 years of follow- up. Am J Ophthalmol. 2015;159:788-96.




2020     |     www.medigraphic.com